Verona Pharma PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
37.60
53.00
53.10
62.00
123.00
98
Gross Income
37.60
53.00
53.10
62.00
123.00
98
SG&A Expense
2,782.80
3,739.80
8,766.40
6,955.00
29,633.00
25,502
EBIT
2,820.40
3,792.80
-
-
29,756.00
25,600
Unusual Expense
-
-
72.30
897.00
6,554.00
1,325
Non Operating Income/Expense
3.60
-
155.30
61.00
2,369.00
1,931
Pretax Income
2,814.20
3,762.80
9,002.30
5,973.00
25,203.00
24,133
Income Tax
289.40
1,004.10
1,509.40
954.00
4,706.00
4,232
Consolidated Net Income
2,524.80
2,758.70
7,492.80
5,019.00
20,497.00
19,901
Net Income
2,524.80
2,758.70
7,492.80
5,019.00
20,497.00
19,901
Net Income After Extraordinaries
2,524.80
2,758.70
7,492.80
5,019.00
20,497.00
19,901
Net Income Available to Common
2,524.80
2,758.70
7,492.80
5,019.00
20,497.00
19,901
EPS (Basic)
0.36
0.16
0.37
7.50
0.23
0.19
Basic Shares Outstanding
7,117.80
17,334.90
20,198.50
670.00
87,748.00
105,110.50
EPS (Diluted)
0.35
0.16
0.37
7.49
0.23
0.19
Diluted Shares Outstanding
7,117.80
17,334.90
20,198.50
670.00
87,748.00
105,110.50
EBITDA
2,782.80
3,739.80
8,766.40
6,955.00
29,633.00
25,502
Non-Operating Interest Income
2.60
30.00
44.80
86.00
368.00
861
About Verona Pharma
View Profile
